Fluorobenzenes
Filtered Search Results
E 2012, MedChemExpress
MedChemExpress E 2012 is a potent gamma (γ) secretase modulator without affecting Notch processing. E 2012 inhibits 3β-hydroxysterol δ24-reductase (DHCR24) at the final step in the cholesterol biosynthesis. E 2012 aims at Alzheimer's disease by reduction of amyloid β-42, and induces cataract following repeated doses in the rat.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 419.49 |
|---|---|
| Color | Light Yellow |
| Physical Form | Solid |
| Chemical Name or Material | E 2012 |
| Grade | Research |
| SMILES | O=C(N([C@H](C1=CC=C(C=C1)F)C)CCC/2)C2=C\C3=CC=C(N4C=NC(C)=C4)C(OC)=C3 |
| For Use With (Application) | Neuroscience-Neurodegeneration |
| Percent Purity | 97.39% |
| CAS | 870843-42-8 |
| Solubility Information | DMSO : ≥ 50 mg/mL (119.19 mM) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C25H26FN3O2 |
| Formula Weight | 419.49 |
E-7386, MedChemExpress
MedChemExpress E-7386 is an orally active CBP/beta-catenin modulator.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 725.85 |
|---|---|
| Color | Off-White |
| Physical Form | Solid |
| Chemical Name or Material | E-7386 |
| Grade | Research |
| SMILES | O=C(N([C@](CN1CC2=NC(N3CC(N4CCN(CC)CC4)C3)=CC=C2)([H])N5[C@@H](CC6=CC=C(O)C=C6F)C1=O)N(CC=C)CC5=O)NCC7=CC=CC=C7 |
| For Use With (Application) | Cancer-programmed cell death |
| Percent Purity | 98.34% |
| CAS | 1799824-08-0 |
| Solubility Information | DMSO : 125 mg/mL (172.21 mM; Need ultrasonic) |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C39H48FN9O4 |
| Formula Weight | 725.85 |
2-Chloro-6-fluorobenzaldoxime, 97%
CAS: 443-33-4 Molecular Formula: C7H5ClFNO Molecular Weight (g/mol): 173.57 MDL Number: MFCD00837704 InChI Key: OBJHLLOVMKKXDI-ONNFQVAWSA-N Synonym: 2-chloro-6-fluorobenzaldehyde oxime,2-chloro-6-fluorobenzaldoxime,6-chloro-2-fluorophenyl hydroxyimino methane,pubchem2883,e-n-2-chloro-6-fluorophenyl methylidene hydroxylamine,1e-2-chloro-6-fluorobenzaldehyde oxime,e-1-2-chloro-6-fluorophenyl-n-hydroxymethanimine,ne-n-2-chloro-6-fluorophenyl methylidene hydroxylamine,ne-n-2-chloranyl-6-fluoranyl-phenyl methylidene hydroxylamine PubChem CID: 7329318 SMILES: O\N=C\C1=C(F)C=CC=C1Cl
| PubChem CID | 7329318 |
|---|---|
| CAS | 443-33-4 |
| Molecular Weight (g/mol) | 173.57 |
| MDL Number | MFCD00837704 |
| SMILES | O\N=C\C1=C(F)C=CC=C1Cl |
| Synonym | 2-chloro-6-fluorobenzaldehyde oxime,2-chloro-6-fluorobenzaldoxime,6-chloro-2-fluorophenyl hydroxyimino methane,pubchem2883,e-n-2-chloro-6-fluorophenyl methylidene hydroxylamine,1e-2-chloro-6-fluorobenzaldehyde oxime,e-1-2-chloro-6-fluorophenyl-n-hydroxymethanimine,ne-n-2-chloro-6-fluorophenyl methylidene hydroxylamine,ne-n-2-chloranyl-6-fluoranyl-phenyl methylidene hydroxylamine |
| InChI Key | OBJHLLOVMKKXDI-ONNFQVAWSA-N |
| Molecular Formula | C7H5ClFNO |
2-chloro-6-fluorophenylboronic acid, 97%, Thermo Scientific™
CAS: 313545-32-3 Molecular Formula: C6H5BClFO2 Molecular Weight (g/mol): 174.36 MDL Number: MFCD04039892 InChI Key: NXSZSZJWZVLHAY-UHFFFAOYSA-N Synonym: 2-chloro-6-fluorophenyl boronic acid,2-chloro-6-fluorobenzeneboronic acid,2-chloro-6-fluorophenylboronicacid,boronic acid, 2-chloro-6-fluorophenyl,boronic acid,b-2-chloro-6-fluorophenyl,boronic acid, b-2-chloro-6-fluorophenyl,pubchem18883,acmc-1ad0v,2-borono-1-chloro-3-fluorobenzene,2-chloro-6-fluorobenzene boronic acid PubChem CID: 3549395 IUPAC Name: (2-chloro-6-fluorophenyl)boronic acid SMILES: OB(O)C1=C(F)C=CC=C1Cl
| PubChem CID | 3549395 |
|---|---|
| CAS | 313545-32-3 |
| Molecular Weight (g/mol) | 174.36 |
| MDL Number | MFCD04039892 |
| SMILES | OB(O)C1=C(F)C=CC=C1Cl |
| Synonym | 2-chloro-6-fluorophenyl boronic acid,2-chloro-6-fluorobenzeneboronic acid,2-chloro-6-fluorophenylboronicacid,boronic acid, 2-chloro-6-fluorophenyl,boronic acid,b-2-chloro-6-fluorophenyl,boronic acid, b-2-chloro-6-fluorophenyl,pubchem18883,acmc-1ad0v,2-borono-1-chloro-3-fluorobenzene,2-chloro-6-fluorobenzene boronic acid |
| IUPAC Name | (2-chloro-6-fluorophenyl)boronic acid |
| InChI Key | NXSZSZJWZVLHAY-UHFFFAOYSA-N |
| Molecular Formula | C6H5BClFO2 |
Rufinamide, MedChemExpress
MedChemExpress Rufinamide(E 2080; CGP 33101; RUF 331) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 238.19 |
|---|---|
| Color | White |
| Physical Form | Solid |
| Chemical Name or Material | Rufinamide |
| Grade | Research |
| SMILES | O=C(C1=CN(CC2=C(F)C=CC=C2F)N=N1)N |
| For Use With (Application) | Neuroscience-Neurodegeneration |
| Percent Purity | 99.88% |
| CAS | 106308-44-5 |
| Solubility Information | DMSO : 50 mg/mL (209.92 mM; Need ultrasonic) |
| Synonym | CGP 33101 E 2080 RUF 331 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C10H8F2N4O |
| Formula Weight | 238.19 |
Golvatinib, MedChemExpress
MedChemExpress Golvatinib (E-7050) is a potent dual inhibitor of both c-Met and VEGFR2 kinases with IC50s of 14 and 16 nM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 633.69 |
|---|---|
| Color | White |
| Physical Form | Powder |
| Chemical Name or Material | Golvatinib |
| Grade | Research |
| SMILES | O=C(NC1=CC=C(C=C1F)OC2=CC(NC(N3CCC(CC3)N4CCN(CC4)C)=O)=NC=C2)C5(CC5)C(NC6=CC=C(C=C6)F)=O |
| For Use With (Application) | Cancer-Kinase/protease |
| Percent Purity | 99.15% |
| CAS | 928037-13-2 |
| Solubility Information | DMSO : 50 mg/mL (78.90 mM; Need ultrasonic) |
| Synonym | E-7050 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C33H37F2N7O4 |
| Formula Weight | 633.69 |
3,4-Difluorobenzamidoxime, 97%, Thermo Scientific™
CAS: 500024-74-8 Molecular Formula: C7H6F2N2O Molecular Weight (g/mol): 172.14 MDL Number: MFCD06660194,MFCD06796653 InChI Key: OGCLGUHODKKLSH-UHFFFAOYSA-N Synonym: 3,4-difluorobenzamidoxime,3,4-difluoro-n-hydroxy-benzamidine,3,4-difluoro-n'-hydroxybenzene-1-carboximidamide,3,4-difluorophenyl hydroxyimino methylamine,benzenecarboximidamide, 3,4-difluoro-n-hydroxy,z-3,4-difluoro-n'-hydroxybenzene-1-carboximidamide,e-3,4-difluoro-n'-hydroxybenzenecarboximidamide PubChem CID: 17750753 IUPAC Name: 3,4-difluoro-N'-hydroxybenzenecarboximidamide SMILES: NC(=NO)C1=CC(F)=C(F)C=C1
| PubChem CID | 17750753 |
|---|---|
| CAS | 500024-74-8 |
| Molecular Weight (g/mol) | 172.14 |
| MDL Number | MFCD06660194,MFCD06796653 |
| SMILES | NC(=NO)C1=CC(F)=C(F)C=C1 |
| Synonym | 3,4-difluorobenzamidoxime,3,4-difluoro-n-hydroxy-benzamidine,3,4-difluoro-n'-hydroxybenzene-1-carboximidamide,3,4-difluorophenyl hydroxyimino methylamine,benzenecarboximidamide, 3,4-difluoro-n-hydroxy,z-3,4-difluoro-n'-hydroxybenzene-1-carboximidamide,e-3,4-difluoro-n'-hydroxybenzenecarboximidamide |
| IUPAC Name | 3,4-difluoro-N'-hydroxybenzenecarboximidamide |
| InChI Key | OGCLGUHODKKLSH-UHFFFAOYSA-N |
| Molecular Formula | C7H6F2N2O |
Lemborexant, MedChemExpress
MedChemExpress Lemborexant (E-2006) is a reversible, competitive and orally active dual antagonist of the orexin OX1 and OX2 receptors with IC50 values of 6.1 nM and 2.6 nM, respectively. Lemborexant can be treated insomnia.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Molecular Weight (g/mol) | 410.42 |
|---|---|
| Color | White |
| Physical Form | Powder |
| Chemical Name or Material | Lemborexant |
| Grade | Research |
| SMILES | O=C([C@H]1[C@@](C2=CC=CC(F)=C2)(COC3=CN=C(C)N=C3C)C1)NC4=NC=C(F)C=C4 |
| Percent Purity | 99.19% |
| CAS | 1369764-02-2 |
| Solubility Information | DMSO : 100 mg/mL (243.65 mM; Need ultrasonic) |
| Synonym | E-2006 |
| Purity Grade Notes | Research |
| Recommended Storage | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Shelf Life | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molecular Formula | C22H20F2N4O2 |
| Formula Weight | 410.42 |